Edition:
India

DarioHealth Corp (DRIO.OQ)

DRIO.OQ on NASDAQ Stock Exchange Capital Market

1.77USD
17 Nov 2017
Change (% chg)

$0.01 (+0.57%)
Prev Close
$1.76
Open
$1.77
Day's High
$1.77
Day's Low
$1.75
Volume
1,121
Avg. Vol
31,037
52-wk High
$4.70
52-wk Low
$1.41

Chart for

About

DarioHealth Corp, formerly Labstyle Innovations Corp, is a digital health (mHealth) company. The Company is engaged in developing and commercializing a technology providing consumers with laboratory-testing capabilities using smart phones and other mobile devices. The Company's product, Dario, also known as Dario Smart Diabetes... (more)

Overall

Beta: -1.85
Market Cap(Mil.): $18.73
Shares Outstanding(Mil.): 9.75
Dividend: --
Yield (%): --

Financials

BRIEF-Dariohealth Corp Q3 revenue $1.375 million

* Qtrly basic and diluted loss per share $0.30‍​ Source text for Eikon: Further company coverage:

14 Nov 2017

BRIEF-DarioHealth says selling stockholders may offer from time to time up to 2.9 mln shares of common stock‍​

* DarioHealth Corp - selling stockholders may offer from time to time up to 2.9 million shares of co's common stock - SEC filing‍​ Source text: (http://bit.ly/2hQHQQg) Further company coverage:

20 Oct 2017

BRIEF-DarioHealth launches into the German diabetes market

* DarioHealth Corp - expects launch into German market to help company reach its Q4 revenue goals and FY2017 annual milestones Source text for Eikon: Further company coverage:

03 Oct 2017

BRIEF-Dariohealth raises $4.28 mln through private placement offerings

* Dariohealth raises $4.28 million through private placement offerings

17 Aug 2017

BRIEF-DarioHealth Q2 loss per share $ 0.43

* DarioHealth Corp - qtrly net loss per share $ 0.43 Source text for Eikon: Further company coverage:

14 Aug 2017

BRIEF-DarioHealth partners with Byram Healthcare

* Dariohealth corp - ‍expanding its insurance coverage provider network by entering into a strategic agreement with byram healthcare​

25 Jul 2017

BRIEF-Dariohealth announces strategic partnership with CCS Medical

* Dariohealth announces strategic partnership with CCS Medical

24 Jul 2017

BRIEF-Dariohealth recieves "first choice" recognition in 3 UK regions

* Dariohealth corp - ‍CCGS in three UK regions have named dario blood glucose monitoring system first choice for all patients with type 1 diabetes​ Source text for Eikon: Further company coverage:

10 Jul 2017

Competitors

Earnings vs. Estimates